Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Rank in Stocks #3215
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Share Price
$44.42
Last synced: 2026-08-25
Market Cap
$5.90B
Change (1 day)
2.66%
Change (1 year)
344.66%
Country
US
Trade Definium Therapeutics, Inc. (DFTX)

Category

Stock split history for Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. stock (symbol: DFTX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 26, 2026.
One DFTX share bought prior to Aug 26, 2026 would equal to 0 DFTX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH